Threeyear outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A

dc.article.end-page1893en
dc.article.start-page1880en
dc.citation.doi10.1016/J.JTHA.2024.04.001en
dc.contributor.authorB Madanen
dc.contributor.authorM OZELOen
dc.contributor.authorP Rahejaen
dc.contributor.authorE Symingtonen
dc.contributor.authorE et alen
dc.contributor.authorJohnny Mahlanguen
dc.date.accessioned2024-09-29T13:39:12Z
dc.date.available2024-09-29T13:39:12Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn1538-7933en
dc.identifier.urihttps://hdl.handle.net/10539/41194
dc.journal.titleThreeyear outcomes of valoctocogene roxaparvovec gene therapy for hemophilia Aen
dc.journal.volume22en
dc.publisherWILEY-BLACKWELLen
dc.titleThreeyear outcomes of valoctocogene roxaparvovec gene therapy for hemophilia Aen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal Article.pdf
Size:
1.18 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client